NSC |
Compound |
Enrichment |
Correlation |
NSC 727985 |
NSC 708781 incorporated in micelles, 0.55% (w/w) of drug |
0.00206000157707805 |
-0.027718809 |
NSC 745451 |
Null |
0.00206000157707805 |
-0.13610177 |
NSC 115980 |
Null |
0.00206000157707806 |
-0.057172998 |
NSC 673191 |
Null |
0.00306027196853062 |
-0.11103095 |
NSC 681151 |
Benzoic acid, 4-[[(3,6-dioxo-1,4-cyclohexadienyl)methyl] amino]-, 1-adamantyl ester |
0.00306027196853062 |
0.089432283 |
NSC 692655 |
D-Homo-17a-aza-5-androsteno[17,16-c]pyrazol-3-yl,2'-(4-fluorophenyl)-, acetate |
0.00306027196853062 |
0.30210453 |
NSC 708244 |
Indolo[3,2-d]benzazepin-6(5H)-one, 9-cyano-2,3-dimethoxy-~7,12-dihydro- |
0.00306027196853062 |
0.13191283 |
NSC 720379 |
Null |
0.00306027196853062 |
-0.25649688 |
NSC 201290 |
Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- |
0.00347157511980527 |
0.15766927 |
NSC 642321 |
Null |
0.00347157511980527 |
0.11061941 |